Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3Diabetes Mellitus 2Vomiting 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Prostatic Neoplasms 1Premature Birth 1Pre-Eclampsia 1Polycystic Ovary Syndrome 1Parathyroid Neoplasms 1Neoplasms 1Medulloblastoma 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Hairy Cell 1Leukemia, B-Cell 1Leiomyosarcoma 1Hyperparathyroidism, Primary 1Hot Flashes 1HER2 IHC3+ Advanced Colorectal Cancer 1Erectile Dysfunction 1Cognitive Dysfunction 1Carcinoma, Renal Cell 1

Interventions

Tablets 1Metformin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Pre-Eclampsia × Tablets × Clear all
NCT00159536 2019-02-15

PregMet

Norwegian University of Science and Technology

Phase 3 Completed
257 enrolled

Diabetes Mellitus, Polycystic Ovary Syndrome, Pre-Eclampsia, Premature Birth

Data powered by HemOnc (CC BY 4.0) Colophon âš¡